EEE

EASTWOOD BIO-MED CDA INC

No trades
See on Supercharts
Market capitalization
‪47.53 M‬CAD
−0.01CAD
‪−546.60 K‬CAD
‪867.94 K‬CAD
‪20.95 M‬
Beta (1Y)
0.69

About EASTWOOD BIO-MED CDA INC

CEO
Youngsoo Kim
Headquarters
Richmond
Website
Founded
2010
ISIN
CA27783W1059
FIGI
BBG0069FG7T9
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. It is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. Its products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EBM is 0.69 CAD — it has decreased by 21.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange EASTWOOD BIO-MED CDA INC stocks are traded under the ticker EBM.
EBM stock is 27.54% volatile and has beta coefficient of 0.69. Check out the list of the most volatile stocks — is EASTWOOD BIO-MED CDA INC there?
Yes, you can track EASTWOOD BIO-MED CDA INC financials in yearly and quarterly reports right on TradingView.
EBM stock has fallen by 13.75% compared to the previous week, the month change is a 53.33% rise, over the last year EASTWOOD BIO-MED CDA INC has showed a 8.00% decrease.
EBM net income for the last quarter is ‪−54.24 K‬ CAD, while the quarter before that showed ‪−184.23 K‬ CAD of net income which accounts for 70.56% change. Track more EASTWOOD BIO-MED CDA INC financial stats to get the full picture.
Today EASTWOOD BIO-MED CDA INC has the market capitalization of ‪47.53 M‬, it has decreased by 0.63% over the last week.
No, EBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EASTWOOD BIO-MED CDA INC stock right from TradingView charts — choose your broker and connect to your account.
EBM reached its all-time high on Sep 24, 2018 with the price of 8.49 CAD, and its all-time low was 0.06 CAD and was reached on Jul 27, 2017.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EASTWOOD BIO-MED CDA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EASTWOOD BIO-MED CDA INC stock shows the sell signal. See more of EASTWOOD BIO-MED CDA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EASTWOOD BIO-MED CDA INC EBITDA is ‪−396.64 K‬ CAD, and current EBITDA margin is −45.88%. See more stats in EASTWOOD BIO-MED CDA INC financial statements.